Cold & Cough Remedies (Pharmacies) - Australia & Oceania

  • Australia & Oceania
  • Revenue in the Cold & Cough Remedies market is projected to reach US$0.34bn in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 5.77%, resulting in a market volume of US$0.45bn by 2029.
  • In global comparison, most revenue will be generated in China (US$7,826.00m in 2024).
  • In relation to total population figures, per person revenues of US$7.75 are generated in 2024.

Key regions: Canada, United Kingdom, United States, China, Europe

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Cold & Cough Remedies (Pharmacies) market in Australia & Oceania is experiencing steady growth and development due to several factors.

Customer preferences:
Customers in Australia & Oceania have shown a growing preference for over-the-counter cold and cough remedies available in pharmacies. This can be attributed to the convenience and accessibility of these products, as well as the increasing awareness of self-care and the desire for quick relief from common cold and cough symptoms. Additionally, customers in this region are becoming more health-conscious and are actively seeking natural and herbal remedies for their ailments.

Trends in the market:
One noticeable trend in the Cold & Cough Remedies (Pharmacies) market in Australia & Oceania is the increasing demand for natural and herbal remedies. Customers are turning to products that are perceived to be more gentle on the body and have fewer side effects. This trend is driven by the growing interest in holistic health and wellness, as well as the desire to avoid the use of synthetic chemicals. As a result, pharmacies in Australia & Oceania are expanding their product offerings to include a wider range of natural and herbal cold and cough remedies. Another trend in the market is the rising popularity of combination products. Customers are looking for medications that provide relief for multiple symptoms, such as congestion, cough, and sore throat, in a single dosage. This trend is driven by the convenience and cost-effectiveness of combination products, as well as the desire to minimize the number of medications taken. Pharmacies in Australia & Oceania are responding to this trend by stocking a variety of combination cold and cough remedies to meet customer demand.

Local special circumstances:
Australia & Oceania has a unique climate and geography that can contribute to the prevalence of cold and cough symptoms. The region experiences distinct seasons, with winter being the peak time for cold and flu outbreaks. This seasonal variation in illness patterns creates a consistent demand for cold and cough remedies throughout the year. Additionally, the region's proximity to Asia and the Pacific Islands can lead to the introduction of new strains of viruses, further driving the need for effective remedies.

Underlying macroeconomic factors:
The growing population and increasing disposable income in Australia & Oceania are contributing to the growth of the Cold & Cough Remedies (Pharmacies) market. As the population continues to expand, the demand for healthcare products, including cold and cough remedies, is expected to rise. Additionally, the rising disposable income allows customers to spend more on healthcare and wellness products, further fueling the market growth. Furthermore, the region's robust healthcare infrastructure and strong regulatory framework ensure that quality cold and cough remedies are readily available in pharmacies. This instills confidence in customers and encourages them to purchase these products from trusted sources. In conclusion, the Cold & Cough Remedies (Pharmacies) market in Australia & Oceania is developing due to customer preferences for over-the-counter remedies, the increasing demand for natural and herbal products, and the popularity of combination medications. The unique climate and geography of the region, along with the underlying macroeconomic factors of population growth and rising disposable income, further contribute to the market's growth and development.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)